Clinical characteristics, management, and outcomes of 203 patients with non-persistent and persistent catheter-related S. aureus bacteremia after catheter removal and initiation of appropriate antimicrobial therapy.
NOTE: Data are no. (%) of patients, unless otherwise indicated. CRSAB, catheter-related Staphylococcus aureus bacteremia; OR, odds ratio; CI, confidence interval; IQR, interquartile range; MSSA, methicillin-susceptible S. aureus; APACHE II, Acute Physiology and Chronic Health Evaluation II.1
Includes perm catheter (n = 30), Hickman catheter (n = 10), and subcutaneous port catheters (n = 2).2
Includes prosthetic valve (n = 7), synthetic vascular graft (n = 5), and orthopedic device (n = 5).3
Within previous one month.4
Includes septic emboli to lungs (n = 8), deep tissue abscess (n = 6), septic arthritis (n = 1), and osteomyelitis (n = 1).